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ABSTRACT 27 
 28 
Background: In this large multicenter trial, we aimed to assess the effect of aerobic exercise 29 
training in stable coronary artery disease (CAD) patients on cellular markers of endothelial 30 
integrity, and examine their relation with improvement of endothelial function. 31 
Methods: Two-hundred CAD patients (LVEF >40%, 90% male, mean age 58.4±9.1 years) 32 
were randomized on a 1:1 base to a supervised 12-week rehabilitation program of either 33 
aerobic interval training (AIT) or aerobic continuous training (ACT) on a bicycle. At baseline 34 
and after 12 weeks, numbers of circulating CD34+/KDR+/CD45dim endothelial progenitor 35 
cells (EPC), CD31+/CD3+/CD184+ angiogenic T-cells and CD31+/CD42b- endothelial 36 
microparticles (EMP) were analyzed by flow cytometry. Endothelial function was assessed by 37 
flow-mediated dilation (FMD) of the brachial artery.  38 
Results: After 12 weeks of AIT or ACT, numbers of circulating EPC, angiogenic T-cells and 39 
EMP were comparable to baseline levels. Whereas improvement in peak VO2 was correlated 40 
to improvement in FMD (pearson r = 0.17, p = 0.035), a direct correlation of baseline or post-41 
training EPC, angiogenic T-cells and EMP levels with FMD was absent. Baseline EMP related 42 
inversely to the magnitude of the increases in peak VO2 (spearman rho = -0.245, p = 0.027) 43 
and FMD (spearman rho = -0.374, p = 0.001) following exercise training. 44 
Conclusions. Endothelial function improvement in response to exercise training in CAD 45 
patients is not mediated by increased releases of EPC and angiogenic T-cells and/or a 46 
diminished shedding of EMP into the circulation. EMP flow cytometry may be predictive of 47 
the increases in aerobic capacity and endothelial function.  48 
 49 
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INTRODUCTION 53 
 54 
Exercise training is recognized as an important preventive and therapeutic strategy in 55 
cardiovascular disease, in part through its beneficial effects on aerobic capacity and 56 
endothelial function.(19) The strong and independent prognostic role of reduced physical 57 
fitness and endothelial dysfunction has been demonstrated in healthy populations, as well 58 
as in patients with underlying coronary artery disease (CAD) and heart failure. Small single 59 
center studies show that peak oxygen uptake (peak VO2) increases to a larger extent with 60 
aerobic interval training (AIT) at higher intensity compared to moderate intensity continuous 61 
training in patients with metabolic syndrome, after acute coronary syndrome, following 62 
coronary artery bypass surgery and in patients with ischemic heart failure.(18, 20, 31, 32) 63 
Interestingly, in the latter patient group, as well as in patients with metabolic syndrome, AIT 64 
also led to a significantly larger improvement in peripheral endothelial function.(25, 32) The 65 
reason for the superior effect of AIT on endothelial function is not completely understood. It 66 
is, however, conceivable that differences in vascular shear stress patterns between exercise 67 
protocols induce different molecular and cellular responses.  68 
Indeed, the enhanced production of nitric oxide (NO) in response to shear stress plays a 69 
critical role in the beneficial effects of exercise training on endothelial function. In addition, 70 
the anti-inflammatory, free radical reducing and permeability decreasing properties of 71 
exercise may all contribute to improvement of endothelial function.(10)  72 
It has also been suggested that endothelial progenitor cells (EPC) could add to these 73 
favorable changes.(16) EPC are a rather small population of cells that can be mobilized from 74 
the bone marrow into the peripheral blood by various stimuli, such as ischemia and 75 
chemokines. They participate in the repair of endothelial damage, thereby possibly 76 
influencing endothelial function.(16) EPC function is regulated by angiogenic T-cells that 77 
express the platelet endothelial cell adhesion molecule (CD31) and the receptor for stromal-78 
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derived factor 1 (CD184).(14) Thus far, because of small-scale, single-center trials, 79 
heterogeneity in patient populations and inconsistency of study results, it was not possible 80 
to draw firm conclusions on a role for EPC and angiogenic T-cells as mediators of the 81 
training-induced improvement of endothelial function in CAD.(8) 82 
The main objective of the Study on Aerobic INTerval EXercise training in CAD (SAINTEX-CAD) 83 
study was to investigate whether a 12-week program of AIT yields a larger gain in peak VO2 84 
and endothelial function compared to a similar training program of aerobic continuous 85 
training (ACT).(6) The results of this large randomized multicenter study involving 200 CAD 86 
patients demonstrated that AIT and ACT are equal in improving peak VO2 and peripheral 87 
endothelial function.(5) The purpose of this substudy from SAINTEX-CAD is to investigate if 88 
aerobic exercise training (AIT versus ACT) can mobilize EPC and other related cellular blood 89 
markers of endothelial integrity, and to examine the relationship between these blood 90 
markers and the improvement of endothelial function.  91 
 92 
METHODS 93 
 94 
Patients and study design  95 
A detailed description of the rationale and design of the SAINTEX-CAD study has been 96 
published previously.(6) Briefly, 200 stable patients with cardiovascular disease were 97 
enrolled at the Cardiac Rehabilitation centers of the University Hospitals of Antwerp (Center 98 
1, n=100) and Leuven (Center 2, n=100), Belgium, between October 2011 and April 2013. 99 
The main study inclusion criteria were: 1) angiographically documented CAD or previous 100 
acute myocardial infarction (AMI), 2) left ventricular ejection fraction (LVEF) > 40%, 3) 101 
optimal medical treatment, 4) stable with regard to symptoms and medication for at least 4 102 
weeks and 5) included between 4 and 12 weeks following AMI, elective percutaneous 103 
coronary Intervention (PCI) or coronary artery bypass grafting (CABG). Patients were 104 
 5
randomized to either aerobic interval training (AIT) or aerobic continuous training (ACT) on a 105 
1:1 base by an online protocol at Center 1. At baseline and after 3 months, patients 106 
underwent cardiopulmonary exercise testing, vascular function assessment and blood 107 
sampling. The Laboratory of Cellular and Molecular Cardiology of Center 1 served as the 108 
central core laboratory responsible for the EPC and angiogenic T-cell analyses of both 109 
centers. 110 
The study complies with the Declaration of Helsinki, was approved by the local ethics 111 
committees and written informed consent was obtained from each participant. 112 
 113 
Exercise training 114 
Thirty-six supervised exercise sessions were implemented at a rate of 3 sessions a week 115 
during 12 weeks. Patients exercised on a bicycle; exercise load was adjusted in order to 116 
comply with the target heart rate (HR) throughout the 12-week training period. Patients 117 
randomized to the AIT group cycled during 38 min in four 4-min intervals at 90–95% of peak 118 
HR (Figure 1). Each interval was separated by 3-min active pauses, cycling at 50–70% of peak 119 
HR. The session started with 10 min warm up and ended with a 3 min cool-down.  Patients in 120 
the ACT group cycled continuously at an intensity of at least 70-75% of peak HR during 37 121 
min. The session started with 5 min warm-up and ended with a 5 min cool-down.  122 
 123 
Clinical assessments  124 
Cardiopulmonary exercise testing 125 
Cardiopulmonary exercise testing (CPET) was performed at baseline and after 12 weeks 126 
using an individualized cycle ergometer ramp protocol (20 Watt +20 Watt/min or 10 Watt + 127 
10 Watt/min). Breath-by-breath gas exchange measurements allowed on-line determination 128 
of ventilation (VE), oxygen uptake (VO2) and carbon dioxide production (VCO2) every 10 s. 129 
Peak VO2 was determined as the mean value of three measures of VO2 during the final 30 s 130 
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of exercise. The anaerobic threshold (AT) and the respiratory exchange ratio (RER) were 131 
recorded.  132 
 133 
Endothelium-dependent vasodilation 134 
All analyses were performed in the morning, in fasting conditions and in a quiet 135 
temperature-controlled room (21-24°C) by a trained operator that was blinded for the study 136 
intervention. Subjects refrained from exercise, food and caffeine at least 8 hours before the 137 
measurements. Blood pressure was obtained after 10 minutes of rest with an automated 138 
blood pressure monitor. Endothelial function was assessed by flow-mediated dilation (FMD) 139 
of the brachial artery using ultrasound (Center 1, AU5 Ultrasound System, Esaote; Center 2, 140 
GE Healthcare, Vivid 7), according to the International Brachial Artery Reactivity Task Force 141 
guidelines.(7) A high-resolution linear-array vascular probe was used (Center 1, 10 MHz; 142 
Center 2, 5-13 MHz). Patients were positioned supine with the right arm resting on an arm 143 
support; the brachial artery was imaged above the antecubital fossa in the longitudinal 144 
plane. After recording of the baseline diameter for at least 1 minute of stable distension 145 
waveforms, a blood pressure cuff at the forearm was inflated to at least 200 mmHg or 60 146 
mmHg higher than the resting systolic blood pressure. After cuff deflation, images were 147 
recorded for 3 minutes. Images were analyzed using edge-detection software FMD-i by 148 
Flomedi (Flomedi, Brussels, Belgium). FMD was expressed as the change in post-stimulus 149 
diameter as a percentage of the baseline diameter. Analyses were blinded in both study 150 
centers. 151 
 152 
Flowcytometric quantification of cellular markers of endothelial integrity 153 
Quantification of EPC 154 
EPC were defined as CD34+KDR+CD45dim cells.(23) Fixated whole blood (TransFix, Caltag 155 
Medsystems, Buckingham, UK) was processed 2 to 3 days after sampling.(13) Red blood cells 156 
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were lysed using ammonium chloride solution (NH4Cl). After pre-treatment with Fc receptor 157 
blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany), samples were stained with 158 
the following antibodies: CD34-PE-Cy7 (BD Pharmingen, Erembodegem, Belgium), KDR-APC 159 
(R&D Systems, Minnesota, USA), CD45-APC-H7 (BD Pharmingen). Negative controls included 160 
fluorescence-minus-one samples and unstained samples. The nucleic acid dye SYTO 13 (Life 161 
Technologies, Gent, Belgium) allowed exclusion of non-nucleated cells and cellular debris. At 162 
least 1 million total events were recorded on a FACSCanto II flow cytometer (Becton 163 
Dickinson, New Jersey, USA). Numbers of EPC were analyzed using FACSDiva software 164 
(Becton Dickinson, version 6.1.2) and expressed as cells per million CD45+ mononuclear cells 165 
with low forward (FSC) and side scatter (SSC). Briefly, after exclusion of cellular aggregates 166 
(FSC area versus height plot) and debris (SYTO 13 negative), a primary gate was set on the 167 
mononuclear cells. Next, a second gate was set on a CD45 versus SSC dot plot to contain all 168 
CD45dim events, as previously described.(23) CD34+ and KDR+ events were analyzed in this 169 
population. 170 
 171 
Quantification of angiogenic T-cells  172 
Angiogenic T-cells were defined as CD31+CD3+CD184+ cells.(14) After red cell lysis and Fc 173 
receptor blocking at day 2 or 3, fixated whole blood was stained with CD31-FITC, CD3-PerCP, 174 
and CD184-APC antibodies (all from BD Biosciences). Unstained samples and fluorescence-175 
minus-one samples for CD31 and CD184 were used as controls. At least 500.000 total events 176 
were analyzed using FACSDiva software and expressed as cells per million mononuclear cells. 177 
Doublets and aggregates were excluded by selecting singlet cells on a FSC area versus FSC 178 
height plot. 179 
 180 
Quantification of EMP 181 
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EMP were defined as CD31+CD42b- particles smaller than 1 µm (Fluoresbrite YG 1µm 182 
calibration size beads, Polysciences, Eppelheim, Germany). EMP enumeration was 183 
performed only on samples collected at Center 1 (n= 90). For this purpose, platelet poor 184 
plasma (PPP) was produced immediately after blood sampling by double centrifugation at 185 
1550x g. Antibodies used were CD31-PE and CD42b-FITC (both from BD Biosciences). 186 
Samples were analyzed as we previously described, enabling the evaluation of circulating 187 
EMP per µl PPP. (28)  188 
 189 
Biochemical assays 190 
Complete blood count was measured on Advia Haematology Analyzer (ADVIA 2120, Siemens 191 
Healthcare Diagnostics). Levels of creatinine and high sensitivity C-reactive protein (hs-CRP) 192 
were measured using routine laboratory techniques (Dimension Vista 1500 System, 193 
Siemens). Estimated glomerular filtration (eGFR) was calculated using the MDRD formula.  194 
 195 
Statistical analysis 196 
Continuous data are expressed as mean ± standard deviation (SD). Skewed distributed data 197 
(one-sample Kolmogorov Smirnov test) are presented as median (range). Baseline 198 
comparisons were performed using independent sample T test or X2 test where appropriate. 199 
Differences over time between groups (=interaction) were analyzed by univariable two-way 200 
repeated measures analysis of variance (ANCOVA) with age and pathology as covariates.  201 
Whereas no centre-effect was found for peak VO2, FMD values were significantly higher in 202 
center 2. Therefore, ANCOVA for FMD included age, pathology and center as covariates. 203 
Percentual changes of FMD were skewed and therefore expressed as median (range).  204 
Pearson or Spearman correlation coefficients were used for correlations. A stepwise 205 
multiple linear regression analysis was used to assess independent determinants of peak 206 
VO2 changes with adjustment for significant determinants on correlation analysis. All tests 207 
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were two-sided, and a p-value of 0.05 was considered statistically significant. All analyses 208 
were performed using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). 209 
 210 
RESULTS  211 
 212 
Patient characteristics 213 
Demographic and clinical characteristics of the patients are shown in Table 1. Age and 214 
pathology differed significantly, with younger age, more post-AMI and less post-PCI patients 215 
in the AIT group, while other baseline values and pharmacological treatment were similar 216 
between AIT and ACT.  217 
 218 
Baseline levels of endothelial integrity markers  219 
Numbers of circulating EPC, angiogenic T-cells and EMP were not associated with the 220 
presence of cardiovascular risk factors like hypertension, diabetes and smoking  (all p>0.05). 221 
In addition, numbers did not correlate with age, hs-CRP or eGFR (all p>0.05). There were no 222 
differences in EPC, angiogenic T-cells and EMP numbers between post-AMI, post-PCI or post-223 
CABG patients (all p>0.05). 224 
 225 
Changes in clinical parameters post-training 226 
As previously reported, mean training intensity was 88% of peak HR in the AIT group and 227 
80% of peak HR in the ACT group.(5) Peak VO2 was significantly higher in both groups after 228 
12 weeks (AIT 22.7±17.6% versus ACT 20.3±15.3%; p-time<0.001, Table 2). In addition, FMD 229 
improved significantly in both groups (AIT median 34.1% (range -69.8 to 646%) and ACT 230 
median 7.14% (range -66.7% to 503%); p-time<0.001). The improvement in peak VO2 was 231 
correlated to improvement in FMD (pearson r = 0.17, p = 0.035). Improvements in both 232 
outcomes were comparable for both training interventions. 233 
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 234 
Changes in numbers of EPC, angiogenic T-cells and EMP post-training 235 
After 12 weeks of AIT or ACT, numbers of EPC, angiogenic T-cells and EMP in peripheral 236 
blood were comparable to baseline levels (all p>0.05, Table 2). This was observed for both 237 
AIT and ACT groups. Results were comparable between the three different etiologies: we 238 
observed no significant change in the number of EPC, angiogenic T-cells or EMP, neither in 239 
the post-AMI group, nor in the post-PCI or post-CABG group (all p>0.05). Various clinical (age, 240 
BMI and systolic blood pressure) and biochemical variables (hs-CRP, eGFR, LDL cholesterol 241 
and leukocytes) were evaluated for their possible interference effects on EPC, angiogenic T-242 
cells and EMP. None of these variables were related to changes in markers of endothelial 243 
integrity (all p>0.05).   244 
 245 
Cellular markers as predictors of the training-induced response 246 
At baseline, no correlations were observed between cellular markers and endothelial 247 
function or aerobic capacity. However, baseline numbers of EMP were related to the 248 
magnitude of the change in peak VO2 (spearman rho = -0.245, p = 0.027) and the change in 249 
FMD (spearman rho = -0.374, p = 0.001) following exercise training. For this analysis, the 250 
total cohort was pooled (AIT and ACT) since an interaction term was absent and EMP 251 
numbers were logarithmically transformed. These relations were maintained in multivariate 252 
regression analysis of logarithmically transformed EMP numbers and after correction for 253 
baseline peak VO2 and age, variables that were related to the change in peak VO2 in 254 
univariate analysis (beta -0.263, p = 0.01). Baseline EPC or angiogenic T-cells did not 255 
correlate with changes in FMD or peak VO2.  256 
 257 
 258 
 259 
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DISCUSSION 260 
 261 
To our knowledge, the current substudy of the SAINTEX-CAD trial is the largest randomized, 262 
multicenter study evaluating the effect of exercise training on cellular blood markers of 263 
endothelial integrity in stable CAD patients. Despite a significant improvement in peripheral 264 
endothelial function, we found no meaningful changes in the numbers of circulating EPC, 265 
angiogenic T-cells and EMP after 12 weeks of AIT or ACT. EMP counts at baseline, however, 266 
were related to the improvements in peak VO2 and FMD at completion of the training 267 
program. 268 
 269 
Blood related markers of endothelial damage and repair 270 
Endothelial dysfunction precedes overt atherosclerosis by many years and is an independent 271 
prognostic marker of cardiovascular events.(22) Disruption of endothelial homeostasis 272 
results from imbalances in the production of nitric oxide and reactive oxygen species, local 273 
and systemic low-grade inflammation and loss of endothelial cells by apoptosis.(4) The injury 274 
of the vessel wall leads to the recruitment of circulating EPC and angiogenic T-cells to the 275 
site of endothelial disruption. It is well known from human and animal studies that EPC and 276 
angiogenic T-cells, which stimulate EPC function, actively participate in the repair of 277 
damaged endothelium.(29, 30) Moreover, endothelial repair seems to improve with their 278 
increased numbers in the circulation, reflecting a higher regenerative capacity.  279 
High levels of EMP affect the endothelial cell layer lining in a negative manner, in contrast to 280 
EPC and angiogenic T-cells. EMP are shed from the plasma membrane of endothelial cells 281 
upon their activation, apoptosis or injury.(12) These small particles may contribute to 282 
worsening of endothelium injury by impairing the endothelium-dependent vasodilation and 283 
modulating inflammation via leukocyte activation and trans-endothelial migration.(9) 284 
 285 
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Impact of exercise training on endothelial function and endothelial repair  286 
This is the first study to examine the influence of exercise training on circulating levels of 287 
EMP and angiogenic T-cells in patients with CAD. Data regarding the impact of physical 288 
training on the number of EPC, however, are conflicting. One recent study reported an 289 
increase in CD34+KDR+CD45dim EPC at the completion of a 4 week aerobic exercise training 290 
program in 61% of stable patients with a previous AMI (n=112).(3) In that study, patients in 291 
the lowest tertile of baseline hs-CRP were most likely of obtaining an increase in EPC. 292 
Variations in peak VO2 were correlated with variations in EPC, and patients without an 293 
increase in peak VO2 (n = 26) demonstrated a lower improvement in EPC number as 294 
compared to patients with an increase in peak VO2. Likewise, Ikeda et al. described that a 3 295 
month walking program of > 4 hours walking per week, led to a gain in aerobic capacity and 296 
CD34+CD133+ EPC number in patients with recent AMI (n=23).(15) Moreover, Steiner et al. 297 
provided evidence supporting a role for increased CD34+KDR+CD133+ EPC in the 298 
augmentation of endothelial function during exercise in CAD patients (n=20).(24) Three 299 
months of aerobic exercise training resulted into a higher EPC level, which was positively 300 
correlated with the change in FMD. Paul et al. also reported a rise in CD133+KDR+ EPC in 35 301 
out of 46 CAD patients after three months of aerobic exercise training.(21) Brachial artery 302 
FMD, however, was not improved and did not correlate with the number of EPC. In addition, 303 
the reduction in plasma hs-CRP was modest and did not reach statistical significance at 304 
program completion. Finally, Luk et al. (n = 32) and Hansen et al. (n = 47) did not find a 305 
significant increase in CD34+KDR+ EPC in patients with CAD after 8 and 6 weeks of aerobic 306 
exercise respectively.(11, 17) Although we must acknowledge the considerable variation in 307 
EPC phenotypes, our results are more consistent with these latter studies, indicating that 308 
EPC, angiogenic T-cells and EMP are not critically involved in mediating the training-induced 309 
improvement of endothelial function in CAD patients.   310 
 311 
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Responders to exercise training 312 
To date, it is widely recognized that the individual response to exercise training in terms of 313 
aerobic capacity is highly variable among patients. Aerobic capacity is one of the strongest 314 
prognosticators in cardiovascular disease, but 20% of patients have a low or absent response 315 
in peak VO2 to training.(1) The mechanisms driving this variability are not well understood 316 
nor do we have good predictors of the response to exercise therapy. Heritability accounts 317 
for 45–50% of the anticipated effect of exercise training.(2) In the present study, EMP count 318 
at baseline was an important within-patient predictor of the change in peak VO2 and 319 
peripheral endothelial function at completion of a 3-month training program. Although 320 
additional studies are needed to confirm its predictive value, EMP flow cytometry may offer 321 
guidance to clinicians and physiotherapists in order to tailor exercise protocols to the need 322 
of individual patients and thereby maximize the beneficial effects.  323 
 324 
Limitations 325 
The definition of EPC is still a matter of debate. In our study, EPC enumeration was 326 
performed according to the recommendations of Van Craenenbroeck et al.(27) The 327 
phenotypic profile of EMP may change according to the type of vascular injury (activation or 328 
apoptosis). It is therefore unlikely that our set of markers efficiently labeled the entire EMP 329 
population. A final limitation is that we could not include a functional analysis of circulating 330 
angiogenic cells in this study design. Circulating angiogenic cells contribute to endothelial 331 
repair in a paracrine fashion. In previous work, we found that exercise induces favorable 332 
effects on the functional capacity of these cells in chronic heart failure patients.(26) 333 
 334 
Conclusions 335 
Our results demonstrate that the improvement of endothelial function in response to 336 
exercise training in stable CAD patients is not mediated by an increased release of EPC and 337 
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angiogenic T-cells nor to a diminished shedding of EMP into the peripheral circulation. EMP 338 
counts at baseline, however, may be predictive of the extent of increase in aerobic capacity 339 
and endothelial function at completion of the training program.  340 
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FIGURE LEGENDS 474 
 475 
Figure 1. Schematic illustration of both training programs.  476 
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TABLES 485 
 486 
Table 1. Demographic and clinical characteristics at baseline 487 
 488 
 AIT
n=100 
ACT
n=100 
P-value 
Age (yrs) 57.0 ± 8.8 59.9 ± 9.2 0.023 
Gender (M/F) 91/9 89/11 NS 
LVEF (%) 57.1 ± 8.5 56.8 ± 7.7 NS 
Cardiovascular risk  
Body mass index (kg/m2) 28.0 ± 4.4 28.5 ± 4.3 NS 
Diabetes (%) 20 18 NS 
Hypertension (%) 58 46 NS 
Smoking (%) 73 74 NS 
Reason for referral  
CABG (%) 26 34 NS 
Elective PCI (%) 7 18 0.019 
AMI (%) 67 48 0.007 
Laboratory measurements  
Hemoglobin (g/dl) 14.3 ± 1.3 14.2 ± 1.4 NS 
Leukocytes (cells/µl) 6698 ± 1575 1042 ± 2094 NS 
eGFR (ml/min/1.73 m2) 78.9 ± 12.9 77.5 ± 12.6 NS 
hs-CRP (mg/l) 4.71 ± 9.4 3.45 ± 7.2 NS 
Exercise Capacity  
Peak VO2 (ml/kg/min) 23.3 ± 5.8 22.2 ± 5.6 NS 
% VO2predicted 82.8 ± 22.6 83.3 ± 22.7 NS 
Maximal workload 
(Watts) 
152 ± 39 144 ± 41 NS 
Medication  
Statin (%) 97 99 NS 
Aspirin (%) 93 95 NS 
Beta-blocker (%) 84 83 NS 
ACE-inhibitor/ARB (%) 77 72 NS 
Values are mean (±SD) or percentage (%). NS: not significant. 489 
 23
LVEF= left ventricular ejection fraction; CABG= coronary artery bypass graft; PCI= 490 
percutaneous coronary intervention; AMI= acute myocardial infarction; eGFR= estimated 491 
glomerular filtration rate; hs-CRP= high sensitivity C-reactive protein; VO2= oxygen uptake; 492 
ACE= angiotensin converting enzyme; ARB= angiotensin II receptor blocker 493 
 494 
  495 
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Table 2. Endothelial function and endothelial integrity markers following AIT or ACT 496 
 AIT ACT  
 0 weeks  12 weeks 0 weeks 12 weeks F value 
time 
F value 
Interaction 
Peak VO2  
(ml/kg/min) 
23.5 ± 5.7 28.6 ±6.9 22.4 ±5.6 26.8 ±6.7 28.18 * 0.16 (NS) 
FMD (%) 5.26 ±3.02 6.47 ±2.79 5.61 ±2.36 6.68 ±3.04 7.28 * 0.06 (NS)
EPC (/106 MNC) 8.2 (0-51) 7.4 (0-53) 9.5 (0-37) 10.6 (0-106) 0.13 (NS) 1.8 (NS) 
Angiogenic T-cells 
(/106 MNC)  
1901 (186-
20494) 
1950 (117-
26247) 
2744 (132-
24000) 
4765 (164-
31392) 
0.95 (NS) 1.23 (NS) 
EMP (/µl) 129 (47-756) 192 (47-755) 227 (80-715) 260 (60-922) 0.0 (NS) 0.8 (NS) 
Values are mean (±SD) or median (range) * p< 0.001, NS: not significant. EPC, angiogenic T-497 
cells and EMP data were log transformed before analysis. ANCOVA with age and pathology 498 
as covariates was performed to test time and interaction effects.  499 
AIT= aerobic interval training; ACT= aerobic continuous training; VO2= oxygen uptake; FMD= 500 
flow mediated dilation; EPC= endothelial progenitor cells; EMP= endothelial microparticles; 501 
MNC= mononuclear cells.  502 
 503 

